Colrain Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,600
| Closed | -$574K | – | 30 |
|
|
2021
Q1 | $574K | Hold |
15,600
| – | – | 0.59% | 22 |
|
|
2020
Q4 | $574K | Sell |
15,600
-842
| -5% | -$30.9K | 1.17% | 17 |
|
|
2020
Q3 | $573K | Sell |
16,442
-5,150
| -24% | -$181K | 1.38% | 17 |
|
|
2020
Q2 | $670K | Sell |
21,592
-18,445
| -46% | -$627K | 1.47% | 16 |
|
|
2020
Q1 | $1.24M | Sell |
40,037
-14,229
| -26% | -$485K | 2.33% | 17 |
|
|
2019
Q4 | $2.02M | Sell |
54,266
-4,111
| -7% | -$146K | 2.11% | 19 |
|
|
2019
Q3 | $1.99M | Sell |
58,377
-8,221
| -12% | -$299K | 2.19% | 19 |
|
|
2019
Q2 | $2.74M | Sell |
66,598
-17,602
| -21% | -$699K | 3.07% | 14 |
|
|
2019
Q1 | $3.39M | Sell |
84,200
-831
| -1% | -$33.3K | 3.98% | 12 |
|
|
2018
Q4 | $3.52M | Hold |
85,031
| – | – | 4.57% | 10 |
|
|
2018
Q3 | $3.56M | Hold |
85,031
| – | – | 3.79% | 14 |
|
|
2018
Q2 | $2.93M | Sell |
85,031
-15,652
| -16% | -$535K | 3.45% | 14 |
|
|
2018
Q1 | $3.39M | Sell |
100,683
-20,313
| -17% | -$698K | 3.59% | 14 |
|
|
2017
Q4 | $4.16M | Sell |
120,996
-75,151
| -38% | -$2.56M | 3.44% | 12 |
|
|
2017
Q3 | $6.64M | Sell |
196,147
-18,108
| -8% | -$582K | 3.05% | 13 |
|
|
2017
Q2 | $6.83M | Sell |
214,255
-88,009
| -29% | -$2.78M | 2.77% | 14 |
|
|
2017
Q1 | $9.81M | Sell |
302,264
-141,971
| -32% | -$4.48M | 2.95% | 10 |
|
|
2016
Q4 | $13.7M | Buy |
444,235
+1,397
| +0.3% | +$42.6K | 2.87% | 13 |
|
|
2016
Q3 | $14.2M | Sell |
442,838
-57,996
| -12% | -$1.94M | 3.22% | 8 |
|
|
2016
Q2 | $16.7M | Sell |
500,834
-173,831
| -26% | -$5.55M | 3.34% | 8 |
|
|
2016
Q1 | $19M | Sell |
674,665
-218,495
| -24% | -$6.24M | 3.3% | 8 |
|
|
2015
Q4 | $27.4M | Buy |
893,160
+34,458
| +4% | +$1.08M | 2.77% | 19 |
|
|
2015
Q3 | $25.6M | Sell |
858,702
-65,882
| -7% | -$2.11M | 2.67% | 18 |
|
|
2015
Q2 | $29.4M | Sell |
924,584
-92,962
| -9% | -$3.03M | 2.59% | 18 |
|
|
2015
Q1 | $33.6M | Sell |
1,017,546
-116,020
| -10% | -$3.69M | 2.8% | 16 |
|
|
2014
Q4 | $33.5M | Sell |
1,133,566
-65,348
| -5% | -$1.87M | 2.59% | 15 |
|
|
2014
Q3 | $33.6M | Sell |
1,198,914
-7,881
| -0.7% | -$221K | 2.51% | 16 |
|
|
2014
Q2 | $34M | Sell |
1,206,795
-13,746
| -1% | -$392K | 2.45% | 17 |
|
|
2014
Q1 | $37.2M | Sell |
1,220,541
-105,611
| -8% | -$3.15M | 2.77% | 14 |
|
|
2013
Q4 | $38.5M | Sell |
1,326,152
-107,026
| -7% | -$3.11M | 2.67% | 14 |
|
|
2013
Q3 | $39.1M | Sell |
1,433,178
-136,522
| -9% | -$3.71M | 2.91% | 14 |
|
|
2013
Q2 | $41.7M | Buy |
+1,569,700
| New | +$43.4M | 3.04% | 10 |
|
Other funds holding PFE
Colrain Capital's PFE Position: Q2 2021 in Review
Colrain Capital sold out of Pfizer (PFE) in Q2 2021, closing a stake of 15,600 shares — an estimated $574K sold.
Colrain Capital first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $41.7M in Q2 2013. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Colrain Capital reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
- Colrain Capital sold 15,600 Pfizer shares in Q2 2021, an estimated $574K.
- Colrain Capital first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Colrain Capital's Pfizer position peaked at $41.7M in Q2 2013.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Colrain Capital's 13F filing for Q2 2021, filed 13 Aug 2021.